Hematology/Oncology

• FDA approves non-invasive therapy for glioblastoma

• HemOnc Today, May 10, 2011
• The FDA announced approval of the NovoTTF-100A System for the treatment of adult patients with glioblastoma multiforme brain tumors, following tumor...More »

• In the Journals

• Prior surgery, lesion location may be linked to higher-grade meningiomas

• HemOnc Today, May 10, 2011
• Patients presenting with nonskull base lesions were at double the risk for grade 2 or 3 tumors as patients with skull base lesions, according to study...More »

• FDA panel: Benefits outweigh risks of non-invasive therapy for glioblastoma

• March 18, 2011
• The FDA Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted 7 to 3 in favor of the NovoTTF-100A System for patients with...More »

• In the Journals

• Glioma risk may be inversely related to atopic conditions

• HemOnc Today, March 10, 2011
• Inverse associations between gliomas and atopic conditions were observed in a case-control study involving friends and siblings of glioma patients,...More »

• In the Journals

• Restoration of NFKBIA gene inhibited tumor growth, increased chemosensitivity in glioblastoma multiforme

• HemOnc Today, February 10, 2011
• Increased expression of the NFKBIA gene inhibited cell growth in glioblastoma tumors with epidermal growth factor receptor amplification and normal NFKBIA...More »

• Imaging Analysis

• Chondrosarcoma of the petroclival synchondrosis

• HemOnc Today, January 10, 2011
  Daniel E. Meltzer, MD; Ali Noor, MD; Yinghua Pang, MD; Arzu Buyuk, MD; Munir Ghesani, MD
• The patient is a 57-year-old, right-handed, retired postal worker. He presented with a chief complaint of left-sided facial tingling. The episodes of...More »

• In the Journals

• Adoptive cell therapy associated with complete, durable regression of melanoma brain metastases

• September 1, 2010
• Adoptive cell therapy administered with activated lymphocytes and interleukin-2 produced objective response in 50% of patients with metastatic brain...More »

• BRAIN: 16% of patients with relapsed glioblastoma alive at 30 months

• June 7, 2010
• ASCO 2010 Annual Meeting
  CHICAGO — Updated results from the BRAIN study showed that there were no new safety signals and 16% of patients with relapsed...More »

• NovoTTF-100A improved response, time to treatment failure in recurrent glioblastoma

• June 7, 2010
• ASCO 2010 Annual Meeting
  CHICAGO — Treatment with a portable medical device that disrupts mitosis by delivering electrical fields through scalp...More »

• Hypofractionated radiation produced similar survival as standard radiotherapy, temozolomide in glioblastoma

• June 6, 2010
• ASCO 2010 Annual Meeting
  CHICAGO — There was no statistically significant difference in OS between a hypofractionated 2-week course of radiation,...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!